Company profile for Cellino

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures for these indications. However, current autologous processes are not scalable due to extensive manual han...
Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures for these indications. However, current autologous processes are not scalable due to extensive manual handling, high variability, and expensive facility overhead. Cellino’s vision is to make personalized regenerative medicines viable at large scale for the first time.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
501 Mass Ave Cambridge MA 02139
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Asia Pharma Expo

Not Confirmed

envelop Contact Supplier

Asia Pharma Expo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260324692566/en/Cellino-Named-to-Fast-Companys-Annual-List-of-the-Worlds-Most-Innovative-Companies-of-2026

BUSINESSWIRE
24 Mar 2026

https://www.businesswire.com/news/home/20260317341570/en/Cellino-Appoints-Ed-Tekeian-as-Chief-Operating-Officer

BUSSINESSWIRE
17 Mar 2026

https://www.businesswire.com/news/home/20260128463002/en/Cellino-Co-Founder-Dr.-Marinna-Madrid-Expands-Role-to-Chief-Product-and-Regulatory-Officer-and-Joins-Board-of-Directors

BUSINESSWIRE
28 Jan 2026

https://www.businesswire.com/news/home/20260126363396/en/Cellino-Invited-to-Speak-at-Keystone-Symposia-Conference-Marking-the-20th-Anniversary-of-iPSC-Discovery-in-Kyoto-Japan

BUSINESSWIRE
26 Jan 2026

https://www.businesswire.com/news/home/20260108170102/en/Cellino-and-Polyphron-Partner-to-Make-Personalized-Tissue-Replacement-Routine

BUSINESSWIRE
08 Jan 2026

https://www.businesswire.com/news/home/20250519682444/en/Cellinos-iPSC-Manufacturing-Technology-Receives-FDA-Advanced-Manufacturing-Technology-AMT-Designation

BUSINESSWIRE
19 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty